Home » Topics » Regulatory

Regulatory
RSS

sNDA submitted for Prevacid in pediatric patients

Feb. 21, 2002

No Comments

Commonly used antibiotic shows potential for Rx of multiple sclerosis

Feb. 21, 2002

No Comments

Aciphex indications expanded

Feb. 19, 2002

No Comments

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Feb. 15, 2002

No Comments

Clarinex approved by FDA for perennial allergic rhinitis and chronic idiopathic urticaria

Feb. 14, 2002

No Comments

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

No Comments

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

No Comments

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

No Comments

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

No Comments

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

sNDA submitted for Prevacid in pediatric patients

Commonly used antibiotic shows potential for Rx of multiple sclerosis

Aciphex indications expanded

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Clarinex approved by FDA for perennial allergic rhinitis and chronic idiopathic urticaria

Launch of delayed-release oral suspension formulation of Prevacid

Xenical approved in Canada for use in type 2 diabetics

Tracleer fails to meet primary endpoints in phase III CHF study

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Xopenex approved for pediatric use in bronchospasm

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Regulatory RSS

Regulatory
RSS